Skip to main content
Skip to Footer

The Journal of Neuropsychiatry and Clinical Neurosciences

  • Volume 33
  • Number 4
  • October 2021

Windows to the Brain

Special Articles

Publication date: 19 July 2021

Pages266–279

As a potentially life-threatening disease with no definitive treatment and without fully implemented population-wide vaccination, COVID-19 has created unprecedented turmoil in socioeconomic life worldwide. In addition to physical signs from the ...

https://doi.org/10.1176/appi.neuropsych.20110277

Publication date: 19 July 2021

Pages280–294

Objective: The mechanisms and neuronal networks associated with anxiety in Parkinson’s disease (PD) are incompletely understood. One of the best tools for investigating both component function and neuronal networks associated with psychiatric symptoms is ...

https://doi.org/10.1176/appi.neuropsych.20110272

Publication date: 19 July 2021

Pages295–306

Objective: The relationship between idiopathic and inherited (monogenic) forms of isolated and combined dystonia and psychiatric disorders remains unclear. In the present review, the authors aimed to provide increased clarity on this association through a ...

https://doi.org/10.1176/appi.neuropsych.20110293

Publication date: 15 July 2021

Pages307–313

Cognitive control deficits are one of three primary endophenotypes in depression, and the enhanced targeting of these deficits in clinical and research work is expected to lead to improved depression outcomes. Cognitive control is a set of self-regulatory ...

https://doi.org/10.1176/appi.neuropsych.20090236

Regular Articles

Publication date: 02 July 2021

Pages314–320

Objective: Deep brain stimulation (DBS) is an effective surgical treatment for patients with Parkinson’s disease (PD). DBS therapy, particularly with the subthalamic nucleus (STN) target, has been linked to rare psychiatric complications, including ...

https://doi.org/10.1176/appi.neuropsych.20080205

Publication date: 03 August 2021

Pages328–336

Objective: There are few effective pharmacological treatments for Tourette’s syndrome. Many patients with Tourette’s syndrome experience impairing tic symptoms despite use of available evidence-based treatments. The investigators conducted a small, ...

https://doi.org/10.1176/appi.neuropsych.19080178

Clinical and Research Reports

Publication date: 16 August 2021

Pages337–341

Objective: Persistent fatigue is common among military servicemembers returning from deployment, especially those with a history of mild traumatic brain injury (mTBI). The purpose of this study was to characterize fatigue following deployment using the ...

https://doi.org/10.1176/appi.neuropsych.20100255

Case Report

Treatment in Behavioral Neurology & Neuropsychiatry

Publication date: 03 August 2021

Pages349–355

White matter disorders are increasingly appreciated as capable of disrupting cognitive function, and this impairment may be sufficiently severe to produce the syndrome of white matter dementia. Although recognizing this problem is important for diagnostic ...

https://doi.org/10.1176/appi.neuropsych.21030080

Publication date: 16 August 2021

Pages356–364

Objective: The phenotypes of several psychiatric conditions can very closely resemble delirium; the authors describe such presentations as pseudodelirium. However, because the clinical management of these conditions differs markedly from that of delirium, ...

https://doi.org/10.1176/appi.neuropsych.20120316

Appreciation

Past Issues

View Issues Archive
No.4
View Issue
1 Oct 2024

Vol. 36 | No. 4

No.3
View Issue
1 Jul 2024

Vol. 36 | No. 3

No.2
View Issue
1 Apr 2024

Vol. 36 | No. 2

No.1
View Issue
1 Jan 2024

Vol. 36 | No. 1